[1]
Mardhiyah Fithriana Mufti et al. 2026. Effectiveness, Safety, and Cost-Effectiveness of the Tenofovir/Lamivudine/Dolutegravir (TLD) Regimen Compared to Tenofovir/Lamivudine/Efavirenz (TLE) in HIV Patients: A Narrative Review. Indonesian Journal of Contemporary Multidisciplinary Research. 5, 4 (Aug. 2026), 581–600. DOI:https://doi.org/10.55927/modern.v5i4.53.